Heidi Ko, Medical Director at Labcorp Drug Development, shared a post on LinkedIn:

“Hooray! Abstract titles for ASCO24 have been released!

Is it too early to start a countdown?? I’m looking forward to all the great advancements in oncology that will be practice-changing.

Plenary session abstracts are all excellent, particularly the abstract ‘Comparative effectiveness trial of early palliative care delivered via Telehealth versus in person among patients with advanced lung cancer.’ Really interested to hear the data!

I’m so grateful that we have an opportunity to present our work on immune phenotypes in breast cancer and a super cool machine learning algorithm for Microsatellite Instability (MSI).

Lastly, congratulations to Ranjit Banwait for receiving a Merit award on our poster abstract! Thank you for including me. I’m honored to have contributed to the study.”

Source: Heidi Ko/LinkedIn